trial
as of 2026-07-01Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia
NCTId NCT06957808
at a glance
— · Recruiting
Enrollment 30 (estimated)
Sponsored by King's College London
Primary completion 2027-01-20
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
30 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Triple
Start
2025-01-10
Primary completion
2027-01-20
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
King's College LondonLead Sponsor
Rosetrees TrustCollaborator
South London and Maudsley NHS Foundation TrustCollaborator
Investigators
1
Katherine Beck, Clinical LecturerPrincipal Investigator
Sites
3 total
London, United KingdomLondon, United KingdomBirmingham, United Kingdom
Facts & assertions
4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2027-01-20
Status
RECRUITING
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
investigator